APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence.

Publication date: Feb 06, 2025

Elucidating the relationships between a class I peptide antigen, a CD8 T cell receptor (TCR) specific to that antigen, and the T cell phenotype that emerges following antigen stimulation, remains a mostly unsolved problem, largely due to the lack of large data sets that can be mined to resolve such relationships. Here, we describe Antigen-TCR Pairing and Multiomic Analysis of T-cells (APMAT), an integrated experimental-computational framework designed for the high-throughput capture and analysis of CD8 T cells, with paired antigen, TCR sequence, and single-cell transcriptome. Starting with 951 putative antigens representing a comprehensive survey of the SARS-CoV-2 viral proteome, we utilize APMAT for the capture and single cell analysis of CD8 T cells from 62 HLA A*02:01 COVID-19 participants. We leverage this comprehensive dataset to integrate with peptide antigen properties, TCR CDR3 sequences, and T cell phenotypes to show that distinct physicochemical features of the antigen-TCR pairs strongly associate with both T cell phenotype and T cell persistence. This analysis suggests that CD8 T cell phenotype following antigen stimulation is at least partially deterministic, rather than the result of stochastic biological properties.

Open Access PDF

Concepts Keywords
Antigens Antigens, Viral
Class Antigens, Viral
Covid CD8-Positive T-Lymphocytes
Relationships COVID-19
Unsolved Female
HLA-A*02:01 antigen
HLA-A2 Antigen
HLA-A2 Antigen
Humans
Male
Peptides
Peptides
Phenotype
Receptors, Antigen, T-Cell
Receptors, Antigen, T-Cell
SARS-CoV-2
Single-Cell Analysis
Transcriptome

Semantics

Type Source Name
disease IDO cell
disease MESH COVID-19
disease MESH tumor
disease MESH Allergy
disease MESH Infectious Diseases
disease MESH viral infection
disease IDO blood
disease MESH histocompatibility
drug DRUGBANK Sulpiride
disease MESH infection
disease MESH acute disease
disease IDO assay
drug DRUGBANK Amino acids
drug DRUGBANK L-Threonine
drug DRUGBANK L-Arginine
disease MESH convalescence
disease IDO protein
drug DRUGBANK Hyaluronic acid
disease MESH inflammation
pathway REACTOME Apoptosis
drug DRUGBANK Piroxicam
drug DRUGBANK Isoxaflutole
disease MESH death
disease IDO algorithm
disease IDO acute infection
disease MESH influenza
drug DRUGBANK Coenzyme M
drug DRUGBANK Dextran
drug DRUGBANK Biotin
disease IDO reagent
drug DRUGBANK Dextromethorphan
drug DRUGBANK Edetic Acid
drug DRUGBANK Chromium
disease IDO quality
drug DRUGBANK Nonoxynol-9
disease MESH Data Source
pathway REACTOME Immune System
disease IDO immune response
drug DRUGBANK L-Cysteine
disease MESH Pancreatic Cancer
pathway KEGG Pancreatic cancer
disease MESH autoimmunity
pathway REACTOME TCR signaling
disease IDO history
disease IDO host
disease MESH sequelae
pathway REACTOME Signal Transduction
drug DRUGBANK L-Phenylalanine
pathway REACTOME Infectious disease
disease IDO infectious disease
disease MESH autoimmune disease
disease IDO facility
pathway REACTOME Reproduction

Original Article

(Visited 5 times, 1 visits today)